Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2019 Earnings Conference Call March 30, 2020 4:30 PM ET
Company Participants
Sabrina Martucci Johnson - President and CEO
John Fair - Chief Strategy Officer
Lisa Walters-Hoffert - CFO
Conference Call Participants
Jason Kolbert - Dawson James
Nathan Weinstein - Aegis Capital
Operator
Welcome to the conference call hosted by Daré Bioscience to review the company's financial results for the year ended December 31, 2019, and to provide a general business update. This call is being recorded. My name is Jonathan, and I will be your operator today. With us today are Sabrina Martucci Johnson, Daré's President and Chief Executive Officer; John Fair, Chief Strategy Officer; and Lisa Walters-Hoffert, Chief Financial Officer.
Ms. Johnson, please proceed.
Sabrina Martucci Johnson
Thank you and welcome all of you to our financial results and business update call for Daré. It's a pleasure to have the opportunity to talk about our year-end results and our company highlights, and the upcoming milestones for 2020, and beyond.
So, before I begin, I'd like to remind you that today's discussion will include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that are not statements of historical fact should be considered forward-looking statements. Actual results or events could differ materially from those anticipated or implied by these statements due to known and unknown risks and uncertainties. You should not place undue reliance on forward-looking statements.
Forward-looking statements are qualified in their entirety by the cautionary statements in the company's SEC filings, including our Annual Report on Form 10-K for the year ended December 31, 2019, which was filed on March 27, 2020. I'd also like to point out that the content in this
- Read more current DARE analysis and news
- View all earnings call transcripts